Our focus remains on how Tirzepatide can add value for the appropriate patient, while acknowledging that additional options can help address a large unmet need
Bohman JK, Jacob AK, Nelsen KA, et al
Pharm Ther 136:8293 Biosa A, Outeiro TF, Bubacco L, Bisaglia M (2018) Diabetes mellitus as a risk factor for Parkinsons disease: a molecular point of view
Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia)
Minimal wait times Serving local businesses for over the years with occupational health services
Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications